![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](lx2187contents.gif)
Acta Cryst. (2011). E67, o816-o817 [ doi:10.1107/S1600536811007665 ]
Abstract: There are two independent molecules in the asymmetric unit of the title compound, C28H32ClN3OS (systematic name: 2-chloro-N-{5-[(1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl]-1,3,4-thiadiazol-2-yl}benzamide). In each molecule, the cyclohexyl ring attached to the thiadiazole fragment adopts a classic chair conformation with two of its two methyl groups in the axial positions. In the crystal, pairs of intermolecular N-H
N hydrogen bonds link the molecules into centrosymmetric dimers, which are further linked via C-H
interactions.
Online 9 March 2011
Copyright © International Union of Crystallography
IUCr Webmaster